Our community narratives are driven by numbers and valuation.
ASML’s story is one of quiet dominance at the heart of global tech. Founded in the Netherlands in 1984, ASML started as a joint venture between Philips and ASM International.Read more
Revenue is expected to reach 150–175m in 2026. Gross margins should improve modestly over time.Read more
CRDB's Net Operating Income is projected to grow 21.96% YoY between 2026 - 2030, driven by strong credit appetite from Tanzania and Burundi, and exponential revenue growth from newly issued subsidiaries CRDB Insurance and CRDB Congo, as well as robust non-funded income growth from its digital platforms as usage continues to surge, and diversification towards other financial services solidifies. A positive jaws between gross income and operating expense growth expected to hold during the projected period as subsidiaries become more profitable and staff productivity continues to surge resulting in a projected earnings growth of 24.55% C.A.G.R between 2026 - 2030.Read more
$BLCO & $COO. The Silence After the AGM: A Retail Investor’s Timeline, Findings, and Opinion on an Unprecedented Governance Failure By a Retail Investor and Portfolio Manager (Opinion) --- I.Read more
SSE plc — Investment Memo Investment Thesis SSE is a core UK infrastructure compounder positioned to benefit from the energy transition. It combines: Regulated electricity networks → stable, inflation-linked returns Renewables pipeline → long-term growth Dividend yield → immediate income Hybrid profile: defensive base + structural growth Business Model 1.Read more
The Valuation Model: The Math Behind the $6.65 Target Our valuation is built on a theoretical 2031 "Bull Case" scenario, assuming the successful execution of Commercial Phase 1 and the initiation of Phase 2 at the Fort Cady facility. 2031 Projected Revenue: $550,000,000 USD (Driven by core boric acid production and a ~20% shift into high-margin advanced derivatives like Meta Boric Acid and Ferroboron).Read more
RXRX is a terrible biotech only because the INSIDERS themselves don’t believe in it! All they’re doing is milking the heck out of this doomed stock!Read more
When considering the hypothetical question of what I would buy in the aftermath of another global financial crisis–type event, a few key criteria come to mind. The ideal company should be financially sound, likely to be indiscriminately sold off alongside other financial stocks and well positioned to recover strongly regardless of the future direction of the economic system.Read more
Q2 FY7/26 results update Prioritizing investment in human capital – Q1-2 FY7/26 results were mixed, with sustained high double-digit sales growth and stable high gross margins, with sustained improvement at the parent company level. However, this was offset by an accelerated recruitment profile, which resulted in negative YoY OP growth.Read more



